Skip to main content

Table 2 Independent risk factors for advanced HIV disease

From: Burden, clinical presentation and risk factors of advanced HIV disease in pregnant Mozambican women

Variable

Unadjusted

Adjusted

OR

95%CI

P-value

OR

95% CI

P-value

Age group

 < 20

1

 

0.013

1

 

0.029

20–24

1.37

0.67; 2.77

1.35

0.66; 2.76

25–34

1.89

0.99; 3.61

1.87

0.97; 3.60

 > 35

2.61

1.28; 5.33

2.52

1.21; 5.24

Gestational age at the first ANC visit

0.98

0.96; 1.00

0.115

0.98

0.96; 1.01

0.146

ART start

Before first ANC visit

1

 

0.457

1

 

0.180

After first ANC visit

1.15

0.80; 1.64

1.29

0.89; 1.87

ART Regime

TDF/3TC/EFV

1

 

 < 0.001

1

 

 < 0.001

AZT/3TC/NVP

3.53

2.07; 6.00

3.29

1.91; 5.67

AZT/3TC/LPV/r or ABC

9.05

2.73; 29.97

8.59

2.56; 28.85

Body mass index

0.97

0.93; 1.01

0.134

0.96

0.92; 1.00

0.067

  1. P value (LR-test). Number of observations: 1506 (unadjusted and adjusted ORs were based only on observations with complete information on all variables). ART Antiretroviral therapy, ANC Antenatal care, TDF/3TC/EFV Tenofovir/lamivudine/ efavirenze, AZT/3TC/NVP Zidovudine/ lamivudine/nevirapine